34 There are currently 3 SGLT-2 inhibitors available in the U.S.: canagliflozin (Invokana), dapagliflozin (Farxiga), and empagliflozin (Jardiance)
Finally, descriptive statistics were used to analyze safety endpoints of the randomized treatments in all participants that were exposed to at least one dose [1]
By contrast, the current Ozempic label mainly lists nausea, vomiting, diarrhea, abdominal pain, and constipation as its most common adverse reactions
These personal characteristics play a big role in determining what works best
The most common adverse effects are mild injection-site reactions and rare transient flushing
Frequently Asked Questions What does Verified mean